Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators

F. Boria, L. Chiva, V. Zanagnolo, D. Querleu, N. Martin-Calvo, ME. Căpîlna, A. Fagotti, A. Kucukmetin, C. Mom, G. Chakalova, A. Shamistan, M. Malzoni, F. Narducci, O. Arencibia, F. Raspagliesi, T. Toptas, D. Cibula, D. Kaidarova, MM. Meydanli, M....

. 2021 ; 31 (9) : 1212-1219. [pub] 20210728

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012247
E-zdroje Online Plný text

NLK ProQuest Central od 2018-01-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2018-01-01 do Před 6 měsíci

INTRODUCTION: Comprehensive updated information on cervical cancer surgical treatment in Europe is scarce. OBJECTIVE: To evaluate baseline characteristics of women with early cervical cancer and to analyze the outcomes of the ESGO quality indicators after radical hysterectomy in the SUCCOR database. METHODS: The SUCCOR database consisted of 1272 patients who underwent radical hysterectomy for stage IB1 cervical cancer (FIGO 2009) between January 2013 and December 2014. After exclusion criteria, the final sample included 1156 patients. This study first described the clinical, surgical, pathological, and follow-up variables of this population and then analyzed the outcomes (disease-free survival and overall survival) after radical hysterectomy. Surgical-related ESGO quality indicators were assessed and the accomplishment of the stated recommendations was verified. RESULTS: The mean age of the patients was 47.1 years (SD 10.8), with a mean body mass index of 25.4 kg/m2 (SD 4.9). A total of 423 (36.6%) patients had a previous cone biopsy. Tumor size (clinical examination) <2 cm was observed in 667 (57.7%) patients. The most frequent histology type was squamous carcinoma (794 (68.7%) patients), and positive lymph nodes were found in 143 (12.4%) patients. A total of 633 (54.8%) patients were operated by open abdominal surgery. Intra-operative complications occurred in 108 (9.3%) patients, and post-operative complications during the first month occurred in 249 (21.5%) patients, with bladder dysfunction as the most frequent event (119 (10.3%) patients). Clavien-Dindo grade III or higher complication occurred in 56 (4.8%) patients. A total of 510 (44.1%) patients received adjuvant therapy. After a median follow-up of 58 months (range 0-84), the 5-year disease-free survival was 88.3%, and the overall survival was 94.9%. In our population, 10 of the 11 surgical-related quality indicators currently recommended by ESGO were fully fulfilled 5 years before its implementation. CONCLUSIONS: In this European cohort, the rate of adjuvant therapy after radical hysterectomy is higher than for most similar patients reported in the literature. The majority of centers were already following the European recommendations even 5 years prior to the ESGO quality indicator implementations.

Amsterdam University Medical Centres Amsterdam Noord Holland Netherlands

Azienda Ospedaliero Universitaria di Bologna Policlinico SantOrsola Malpighi Bologna Italy

Bellvitge University Hospital L'Hospitalet de Llobregat Catalunya Spain

Clinic of Obstetrics and Gynecology Hospital San Gerardo Monza Italy

Clinica Universidad de Navarra Departamento de Ginecologia y Obstetricia Madrid Spain

Clinica Universidad de Navarra Departamento de Ginecologia y Obstetricia Pamplona Navarra Spain

Clinical Hospital Center Rijeka Rijeka Croatia

Clinical Hospital Center Zagreb Croatia

Department of Gynaecology LUMC Leiden Netherlands

Department of Gynecologíc Oncology Hospital Universitario La Paz Madrid Madrid Spain

Department of Gynecologic Oncology Saglik Bilimleri University Antalya Research and Training Hospital Antalya Turkey

Department of Gynecologic Oncology Universidad de Navarra Pamplona Navarra Spain

Department of Gynecologic Oncology Zekai Tahir Burak Women's Health Education and Research Hospital Ankara Turkey

Department of Gynecological Oncology Radboudumc Nijmegen Netherlands

Department of Gynecology and Oncology Jagiellonian University Krakow Poland

Department of Gynecology Centre Oscar Lambret Lille France

Department of Gynecology Clinica Universitaria de Navarra Madrid Spain

Department of Gynecology Clinica Universitaria de Navarra Pamplona Navarra Spain

Department of Gynecology Instituto Português de Oncologia de Lisboa Lisboa Lisboa Portugal

Department of Medicine and Surgery University of Milan Bicocca Milano Italy

Department of Obstetrics and Gynecology Clinica Universidad de Navarra Madrid Spain

Department of Obstetrics and Gynecology School of Medicine

Department of Obstetrics and Gynecology Tampere University Hospital Tampere Finland

Department of Obstetrics and Gynecology University of Liege Liege Belgium

Department of Obstetrics and Gynecology University of Prague Prague Czech Republic

Department of Oncogynecology Grigoriev Institute for Medical Radiology NAMS of Ukraine Harkiv Ukraine

Department of Oncological Gynecology Uniwersytet Medyczny im Piastów Śląskich we Wrocławiu Wroclaw Poland

Department of Oncology Radiology and Radiation Medicine 5 N Karazin Kharkiv National University Harkiv Ukraine

Department of Preventive Medicine and Public Health Universidad de Navarra Pamplona Spain

Department of Surgery Fondazione IRCCS Istituto Nazionale dei Tumori Milano Lombardia Italy

Department of Surgery Institut Bergonie Bordeaux France

Department of Surgery LISOD Israeli Oncological Hospital Kyiv region Ukraine

Department of Woman Child and Public Health Fondazione Policlinico Universitario A Gemelli IRCCS Rome Italy

Division of Gynecologic Oncology 1st Department of Obstetrics and Gynecology Alexandra Hospital National and Kapodistrian University of Athens Athens Greece

Emergency County Hospital Targu Mures Targu Mures Romania

Endoscopica Malzoni Center for Advanced Endoscopic Gynecologic Surgery Center for Advanced Endoscopic Gynecologic Surgery Avellino Italy

General Hospital of Thessaloniki Papageorgiou Thessaloniki Central Macedonia Greece

Institut Curie Paris Île de France France

Instituto Português de Oncologia do Porto Francisco Gentil Porto Portugal

Istituto Europeo di Oncologia Milano Anognnn Italy

Kardinal Schwarzenberg'sches Krankenhaus Schwarzach Steiermark Austria

Lviv Oncology Center Lviv Ukraine

National Center of Oncology Baku Azerbaijan

North Estonia Medical Centre Tallinn Estonia

North Western State Medical University N N Petrov Research Institute of Oncology Saint Petersburg Saint Petersburg Russian Federation

Obstetrics and Gynecology Unit of Gynecologic Oncology Institute of Obstetrics and Gynecology Faculty of Medicine University of Debrecen Debrecen Hungary

Oncogynecology Kazahskij Naucno Issledovatel'skij Institut Onkologii i Radiologii Almaty Kazakhstan

Queen Elizabeth Hospital Gateshead Gateshead UK

University Hospitals of Leicester NHS Trust Leicester Leicester UK

University Maternal Hospital Canary Islands Las Palma Spain

University of Navarra Pamplona Spain

University Oncologic Hospital Sofia Bulgaria

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012247
003      
CZ-PrNML
005      
20220506130526.0
007      
ta
008      
220425s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/ijgc-2021-002587 $2 doi
035    __
$a (PubMed)34321289
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Boria, Felix $u Clinica Universidad de Navarra Departamento de Ginecologia y Obstetricia, Madrid, Spain $1 https://orcid.org/0000000247616190
245    10
$a Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators / $c F. Boria, L. Chiva, V. Zanagnolo, D. Querleu, N. Martin-Calvo, ME. Căpîlna, A. Fagotti, A. Kucukmetin, C. Mom, G. Chakalova, A. Shamistan, M. Malzoni, F. Narducci, O. Arencibia, F. Raspagliesi, T. Toptas, D. Cibula, D. Kaidarova, MM. Meydanli, M. Tavares, D. Golub, AM. Perrone, R. Poka, D. Tsolakidis, G. Vujić, MA. Jedryka, PLM. Zusterzeel, JJ. Beltman, F. Goffin, D. Haidopoulos, H. Haller, R. Jach, I. Yezhova, I. Berlev, M. Bernardino, R. Bharathan, M. Lanner, MM. Maenpaa, V. Sukhin, JG. Feron, R. Fruscio, K. Kukk, J. Ponce, M. Alonso-Espías, JA. Minguez, D. Vázquez-Vicente, N. Manzour, M. Jurado, T. Castellanos, E. Chacon, JL. Alcazar
520    9_
$a INTRODUCTION: Comprehensive updated information on cervical cancer surgical treatment in Europe is scarce. OBJECTIVE: To evaluate baseline characteristics of women with early cervical cancer and to analyze the outcomes of the ESGO quality indicators after radical hysterectomy in the SUCCOR database. METHODS: The SUCCOR database consisted of 1272 patients who underwent radical hysterectomy for stage IB1 cervical cancer (FIGO 2009) between January 2013 and December 2014. After exclusion criteria, the final sample included 1156 patients. This study first described the clinical, surgical, pathological, and follow-up variables of this population and then analyzed the outcomes (disease-free survival and overall survival) after radical hysterectomy. Surgical-related ESGO quality indicators were assessed and the accomplishment of the stated recommendations was verified. RESULTS: The mean age of the patients was 47.1 years (SD 10.8), with a mean body mass index of 25.4 kg/m2 (SD 4.9). A total of 423 (36.6%) patients had a previous cone biopsy. Tumor size (clinical examination) <2 cm was observed in 667 (57.7%) patients. The most frequent histology type was squamous carcinoma (794 (68.7%) patients), and positive lymph nodes were found in 143 (12.4%) patients. A total of 633 (54.8%) patients were operated by open abdominal surgery. Intra-operative complications occurred in 108 (9.3%) patients, and post-operative complications during the first month occurred in 249 (21.5%) patients, with bladder dysfunction as the most frequent event (119 (10.3%) patients). Clavien-Dindo grade III or higher complication occurred in 56 (4.8%) patients. A total of 510 (44.1%) patients received adjuvant therapy. After a median follow-up of 58 months (range 0-84), the 5-year disease-free survival was 88.3%, and the overall survival was 94.9%. In our population, 10 of the 11 surgical-related quality indicators currently recommended by ESGO were fully fulfilled 5 years before its implementation. CONCLUSIONS: In this European cohort, the rate of adjuvant therapy after radical hysterectomy is higher than for most similar patients reported in the literature. The majority of centers were already following the European recommendations even 5 years prior to the ESGO quality indicator implementations.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hysterektomie $x metody $7 D007044
650    _2
$a lidé středního věku $7 D008875
650    _2
$a ukazatele kvality zdravotní péče $x normy $7 D019984
650    _2
$a výsledek terapie $7 D016896
650    _2
$a nádory děložního čípku $x chirurgie $7 D002583
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Chiva, Luis $u Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, Madrid, Spain lchiva@unav.es $1 https://orcid.org/0000000219083251
700    1_
$a Zanagnolo, Vanna $u Istituto Europeo di Oncologia, Milano, Anognnn, Italy
700    1_
$a Querleu, Denis $u Department of Surgery, Institut Bergonie, Bordeaux, France $1 https://orcid.org/0000000239844812
700    1_
$a Martin-Calvo, Nerea $u Department of Preventive Medicine and Public Health, Universidad de Navarra, Pamplona, Spain
700    1_
$a Căpîlna, Mihai Emil $u Emergency County Hospital Targu-Mures, Targu Mures, Romania
700    1_
$a Fagotti, Anna $u Department of Woman, Child, and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy
700    1_
$a Kucukmetin, Ali $u Queen Elizabeth Hospital, Gateshead, Gateshead, UK
700    1_
$a Mom, Constantijne $u Amsterdam University Medical Centres, Amsterdam, Noord-Holland, Netherlands
700    1_
$a Chakalova, Galina $u University Oncologic Hospital, Sofia, Bulgaria
700    1_
$a Shamistan, Aliyev $u National Center of Oncology, Baku, Azerbaijan
700    1_
$a Malzoni, Mario $u Endoscopica Malzoni, Center for Advanced Endoscopic Gynecologic Surgery, Center for Advanced Endoscopic Gynecologic Surgery, Avellino, Italy
700    1_
$a Narducci, Fabrice $u Department of Gynecology, Centre Oscar Lambret, Lille, France
700    1_
$a Arencibia, Octavio $u University Maternal Hospital Canary Islands, Las Palma, Spain
700    1_
$a Raspagliesi, Francesco $u Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, Italy
700    1_
$a Toptas, Tayfun $u Department of Gynecologic Oncology, Saglik Bilimleri University Antalya Research and Training Hospital, Antalya, Turkey $1 https://orcid.org/0000000267066915
700    1_
$a Cibula, David $u Department of Obstetrics and Gynecology, University of Prague, Prague, Czech Republic
700    1_
$a Kaidarova, Dilyara $u Oncogynecology, Kazahskij Naucno-Issledovatel'skij Institut Onkologii i Radiologii, Almaty, Kazakhstan
700    1_
$a Meydanli, Mehmet Mutlu $u Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey $1 https://orcid.org/0000000167639720
700    1_
$a Tavares, Mariana $u Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal
700    1_
$a Golub, Dmytro $u Department of Surgery, LISOD - Israeli Oncological Hospital, Kyiv region, Ukraine
700    1_
$a Perrone, Anna Myriam $u Azienda Ospedaliero-Universitaria di Bologna Policlinico SantOrsola-Malpighi, Bologna, Italy $1 https://orcid.org/0000000331404772
700    1_
$a Poka, Robert $u Obstetrics and Gynecology, Unit of Gynecologic Oncology, Institute of Obstetrics and Gynecology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary $1 https://orcid.org/0000000318361579
700    1_
$a Tsolakidis, Dimitrios $u General Hospital of Thessaloniki Papageorgiou, Thessaloniki, Central Macedonia, Greece
700    1_
$a Vujić, Goran $u Clinical Hospital Center, Zagreb, Croatia
700    1_
$a Jedryka, Marcin A $u Department of Oncological Gynecology, Uniwersytet Medyczny im Piastów Śląskich we Wrocławiu (Wroclaw Medical University), Wroclaw, Poland $1 https://orcid.org/0000000189350311
700    1_
$a Zusterzeel, Petra L M $u Department of Gynecological Oncology, Radboudumc, Nijmegen, Netherlands
700    1_
$a Beltman, Jogchum Jan $u Department of Gynaecology, LUMC, Leiden, Netherlands
700    1_
$a Goffin, Frederic $u Department of Obstetrics and Gynecology, University of Liege, Liege, Belgium
700    1_
$a Haidopoulos, Dimitrios $u Division of Gynecologic Oncology, 1st Department of Obstetrics and Gynecology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece
700    1_
$a Haller, Herman $u Clinical Hospital Center Rijeka, Rijeka, Croatia
700    1_
$a Jach, Robert $u Department of Gynecology and Oncology, Jagiellonian University, Krakow, Poland
700    1_
$a Yezhova, Iryna $u Lviv Oncology Center, Lviv, Ukraine
700    1_
$a Berlev, Igor $u North-Western State Medical University. N.N. Petrov Research Institute of Oncology, Saint-Petersburg, Saint-Petersburg, Russian Federation
700    1_
$a Bernardino, Margarida $u Department of Gynecology, Instituto Português de Oncologia de Lisboa, Lisboa, Lisboa, Portugal
700    1_
$a Bharathan, Rasiah $u University Hospitals of Leicester NHS Trust, Leicester, Leicester, UK
700    1_
$a Lanner, Maximilian $u Kardinal Schwarzenberg'sches Krankenhaus, Schwarzach, Steiermark, Austria
700    1_
$a Maenpaa, Minna M $u Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland
700    1_
$a Sukhin, Vladyslav $u Department of Oncology, Radiology and Radiation Medicine, V N Karazin Kharkiv National University, Harkiv, Ukraine $u Department of Oncogynecology, Grigoriev Institute for Medical Radiology NAMS of Ukraine, Harkiv, Ukraine $1 https://orcid.org/0000000244033707
700    1_
$a Feron, Jean-Guillaume $u Institut Curie, Paris, Île-de-France, France
700    1_
$a Fruscio, Robert $u Department of Medicine and Surgery, University of Milan-Bicocca, Milano, Italy $u Clinic of Obstetrics and Gynecology, Hospital San Gerardo, Monza, Italy $1 https://orcid.org/0000000156882194
700    1_
$a Kukk, Kersti $u North Estonia Medical Centre, Tallinn, Estonia
700    1_
$a Ponce, Jordi $u Bellvitge University Hospital, L'Hospitalet de Llobregat, Catalunya, Spain
700    1_
$a Alonso-Espías, María $u Department of Gynecologíc Oncology, Hospital Universitario La Paz, Madrid, Madrid, Spain
700    1_
$a Minguez, Jose Angel $u Department of Gynecology, Clinica Universitaria de Navarra, Pamplona, Navarra, Spain
700    1_
$a Vázquez-Vicente, Daniel $u Department of Gynecology, Clinica Universitaria de Navarra, Madrid, Spain $1 https://orcid.org/0000000296185606
700    1_
$a Manzour, Nabil $u Clinica Universidad de Navarra Departamento de Ginecologia y Obstetricia, Pamplona, Navarra, Spain $1 https://orcid.org/0000000246046042
700    1_
$a Jurado, Matias $u Department of Gynecology, Clinica Universitaria de Navarra, Pamplona, Navarra, Spain
700    1_
$a Castellanos, Teresa $u Department of Gynecology, Clinica Universitaria de Navarra, Madrid, Spain
700    1_
$a Chacon, Enrique $u Department of Gynecologic Oncology, Universidad de Navarra, Pamplona, Navarra, Spain $1 https://orcid.org/0000000186598602
700    1_
$a Alcazar, Juan Luis $u Department of Obstetrics and Gynecology, School of Medicine; University of Navarra, Pamplona, Spain $1 https://orcid.org/0000000297000853
773    0_
$w MED00009896 $t International journal of gynecological cancer : official journal of the International Gynecological Cancer Society $x 1525-1438 $g Roč. 31, č. 9 (2021), s. 1212-1219
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34321289 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130518 $b ABA008
999    __
$a ok $b bmc $g 1789716 $s 1163448
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 31 $c 9 $d 1212-1219 $e 20210728 $i 1525-1438 $m International journal of gynecological cancer $n Int J Gynecol Cancer $x MED00009896
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...